Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III extension study of recombinant zoster vaccine (CHO cell) in adults aged 40 years and older
CTR20254023Phase 3Active
- Sponsor
- Ab&B Bio-tech Co., Ltd.
- Start
- Nov 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Yi An Shi in herpes zoster (HZ), sponsored by Ab&B Bio-tech Co., Ltd.. Started Nov 2025; status: active.
02
Drugs
Yi An Shi
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20254023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254023.